Phase 3 Trial of Carboplatin in Triple Negative Breast Cancer Patient with Residual Invasive Carcinoma After Neoadjuvant Chemotherapy(Transitioned to jRCT)
Phase 3
- Conditions
- Triple Negative Breast Cancer
- Registration Number
- JPRN-UMIN000030780
- Lead Sponsor
- Kobe University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 270
Inclusion Criteria
Not provided
Exclusion Criteria
(1) previously treated with Carboplatin (2) other cancer (3) bilateral breast cancer (4) during pregnancy or breast feeding (5) attended clinical trial within 6 month (6) metastatic breast cancer (7) heavy disorder of heat, kidney or liver (8) doctor's dicision of inadequacy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method